Holen Sie sich die Stockscreener-App
92.62
0.37%
0.34
Handel nachbörslich:
92.62
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
LeMaitre Vascular stock holds Neutral rating at Cantor after strong Q2 - Investing.com Nigeria
LeMaitre Vascular, Inc. to Issue Quarterly Dividend of $0.20 (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Up After Earnings Beat - MarketBeat
Cantor Fitzgerald Issues Positive Forecast for LeMaitre Vascular (NASDAQ:LMAT) Stock Price - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) CEO George W. Lemaitre Sells 100,000 Shares - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Announces Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Issues Q3 2025 Earnings Guidance - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Issues FY 2025 Earnings Guidance - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Rating Increased to Outperform at Barrington Research - MarketBeat
LeMaitre Vascular Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Q3 EPS Estimate for LeMaitre Vascular Increased by Analyst - MarketBeat
Q3 Earnings Estimate for LMAT Issued By Barrington Research - MarketBeat
Lemaitre Vascular Insider Sales: Signal of Caution or Strategic Wealth Management? - AInvest
Q2 EPS Estimate for LeMaitre Vascular Lifted by Analyst - MarketBeat
LeMaitre Vascular To Go Ex-Dividend On August 21st, 2025 With 0.2 USD Dividend Per Share - 富途牛牛
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2025 Earnings Call Transcript - Insider Monkey
LeMaitre Vascular’s Earnings Call Highlights Growth - TipRanks
LeMaitre Vascular Beats Expectations With Strong Sales And Profits - Finimize
Why LeMaitre (LMAT) Stock Is Trading Up Today - TradingView
LeMaitre Vascular Breaks Above 200-Day Moving AverageBullish for LMAT - Nasdaq
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Could Be 25% Above Their Intrinsic Value Estimate - simplywall.st
LEMAITRE VASCULAR INC SEC 10-Q Report - TradingView
LeMaitre (LMAT) Q2 Revenue Jumps 15% - sharewise.com
LeMaitre Vascular Reports Impressive Q2 2025 Financial ResultsNews and Statistics - IndexBox
LeMaitre Vascular Q2 Earnings, Revenue Rise; Raises 2025 Guidance - MarketScreener
LeMaitre raises 2025 revenue guidance to $251M with 15% organic growth as international launches accelerate - MSN
LeMaitre: Q2 Earnings Snapshot - New Haven Register
LeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance
LeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: S - GuruFocus
LeMaitre (LMAT) Q2 Revenue Jumps 15% - The Motley Fool
LeMaitre Vascular's Q2 2025 Earnings Call: Unpacking Key Contradictions in Sales Growth, Pricing Strategies, and Market Opportunities - AInvest
LeMaitre Vascular Reports Strong Q2 2025 Growth - TipRanks
LeMaitre Vascular Ups Guidance After Strong Q2 Sales Jump - Finimize
Earnings call transcript: LeMaitre Vascular Q2 2025 earnings beat forecasts By Investing.com - Investing.com Canada
LeMaitre Vascular (LMAT) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
LeMaitre (NASDAQ:LMAT) Exceeds Q2 Expectations, Full-Year Sales Guidance is Optimistic - TradingView
LeMaitre Vascular earnings beat by $0.03, revenue topped estimates - Investing.com South Africa
Medical device firm LeMaitre Q2 sales beat expectations - MarketScreener
LeMaitre Vascular, Inc. Reports Q2 2025 Financial Results, Announces Dividend, and Raises Guidance - Quiver Quantitative
LeMaitre Q2 2025 Financial Results - GlobeNewswire
Why LeMaitre Vascular Inc. stock attracts strong analyst attentionLow Risk Trade Timing with Analysis Metrics - Newser
3.62%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):